Inga Lennes, MD, MPH, MBA

Inga Lennes, MD, MPH, MBA

Research Interests: Outcomes related to supportive care of cancer patients and measuring the quality of oncology care.

Overview

Biography

Inga T. Lennes MD, MPH, MBA grew up in the midwest and came to the east coast for college.  She attended Mount Holyoke College for her undergraduate degree and went on to attend the University of Massachusetts Medical School for her medical degree.  Dr. Lennes completed her internal medicine residency training at Beth Israel Deaconess Medical Center and also was a Chief Medical Resident at BIDMC.  She trained as a Hematology and Oncology Fellow in the Dana Farber/Partners Cancer Care Fellowship.

Dr. Lennes is a medical oncologist in the Center for Thoracic Cancers and specializes in seeing all lung cancers and esophageal cancer. She is the founder and director of the Pulmonary Nodule Clinic at Massachusetts General Hospital and works closely with colleagues to study and implement lung cancer screening and improve nodule management. As the Director of Clinical Quality and the Medical Director for Ambulatory Services, Dr. Lennes is a member of the senior administration team at the Cancer Center.

Research Interests

Quality and safety have been a major theme in my ealiest publications to the most recent ones. From defining best practices to determining how to disseminate high-quality oncology care efficiently and effectively; these are the hallmarks of the work that has dominated my administrative and research career.

End of life care is another key focus in my research career. As a member of the Cancer Outcomes Research Group at MGH Cancer Center, led by Dr. Jennifer Temel and Dr. William Pirl, I am involved in several projects investigating the drivers of end of life care. One important project in this area was creating a survey to address prognostic awareness and using the tool to understand more about the characteristics of patients with regard to their prognostic understanding.

As a member of an important research team at MGH in thoracic malignancies, I have contributed to research that advances our understanding of lung cancer and served on the NCCN Non-Small Cell Lung Cancer panel, aggregating and interpreting scientific evidence and creating guidelines for the national standard of lung cancer care.

Cancer survivorship is a new and evolving field that spans oncology and primary care medicine. Over the past three years, I have created a data registry to begin collecting important clinical and patient-reported outcomes with regard to cancer survivorship. I have mentored junior researchers who have used the database to conduct scientific inquiries.

Back to Top